IBDEI0BE ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5003,1,5,0)
 ;;=5^Erythema Toxic
 ;;^UTILITY(U,$J,358.3,5003,2)
 ;;=^265514
 ;;^UTILITY(U,$J,358.3,5004,0)
 ;;=695.10^^25^264^1
 ;;^UTILITY(U,$J,358.3,5004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5004,1,2,0)
 ;;=2^695.10
 ;;^UTILITY(U,$J,358.3,5004,1,5,0)
 ;;=5^Erythema Multiforme NOS
 ;;^UTILITY(U,$J,358.3,5004,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,5005,0)
 ;;=V15.89^^25^265^6
 ;;^UTILITY(U,$J,358.3,5005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5005,1,2,0)
 ;;=2^V15.89
 ;;^UTILITY(U,$J,358.3,5005,1,5,0)
 ;;=5^Persian Gulf Service
 ;;^UTILITY(U,$J,358.3,5005,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,5006,0)
 ;;=V15.84^^25^265^1
 ;;^UTILITY(U,$J,358.3,5006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5006,1,2,0)
 ;;=2^V15.84
 ;;^UTILITY(U,$J,358.3,5006,1,5,0)
 ;;=5^Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,5006,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,5007,0)
 ;;=V15.85^^25^265^2
 ;;^UTILITY(U,$J,358.3,5007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5007,1,2,0)
 ;;=2^V15.85
 ;;^UTILITY(U,$J,358.3,5007,1,5,0)
 ;;=5^Exposure To Body Fluids
 ;;^UTILITY(U,$J,358.3,5007,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,5008,0)
 ;;=V15.81^^25^265^5
 ;;^UTILITY(U,$J,358.3,5008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5008,1,2,0)
 ;;=2^V15.81
 ;;^UTILITY(U,$J,358.3,5008,1,5,0)
 ;;=5^Noncompliance With Treatment
 ;;^UTILITY(U,$J,358.3,5008,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,5009,0)
 ;;=V15.3^^25^265^3
 ;;^UTILITY(U,$J,358.3,5009,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5009,1,2,0)
 ;;=2^V15.3
 ;;^UTILITY(U,$J,358.3,5009,1,5,0)
 ;;=5^Exposure To Radiation Therapy
 ;;^UTILITY(U,$J,358.3,5009,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,5010,0)
 ;;=V15.82^^25^265^4
 ;;^UTILITY(U,$J,358.3,5010,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5010,1,2,0)
 ;;=2^V15.82
 ;;^UTILITY(U,$J,358.3,5010,1,5,0)
 ;;=5^Exposure To Tobacco
 ;;^UTILITY(U,$J,358.3,5010,2)
 ;;=^303405
 ;;^UTILITY(U,$J,358.3,5011,0)
 ;;=704.09^^25^266^1
 ;;^UTILITY(U,$J,358.3,5011,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5011,1,2,0)
 ;;=2^704.09
 ;;^UTILITY(U,$J,358.3,5011,1,5,0)
 ;;=5^Decalvans Folliculitis
 ;;^UTILITY(U,$J,358.3,5011,2)
 ;;=^87249
 ;;^UTILITY(U,$J,358.3,5012,0)
 ;;=704.8^^25^266^3
 ;;^UTILITY(U,$J,358.3,5012,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5012,1,2,0)
 ;;=2^704.8
 ;;^UTILITY(U,$J,358.3,5012,1,5,0)
 ;;=5^Pustular/Bacterial Folliculitis
 ;;^UTILITY(U,$J,358.3,5012,2)
 ;;=Pustular/Bacterial Folliculitis^87969
 ;;^UTILITY(U,$J,358.3,5013,0)
 ;;=706.1^^25^266^2
 ;;^UTILITY(U,$J,358.3,5013,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5013,1,2,0)
 ;;=2^706.1
 ;;^UTILITY(U,$J,358.3,5013,1,5,0)
 ;;=5^Keloid Folliculitis
 ;;^UTILITY(U,$J,358.3,5013,2)
 ;;=^87239
 ;;^UTILITY(U,$J,358.3,5014,0)
 ;;=680.3^^25^267^1
 ;;^UTILITY(U,$J,358.3,5014,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5014,1,2,0)
 ;;=2^680.3
 ;;^UTILITY(U,$J,358.3,5014,1,5,0)
 ;;=5^Furuncle Of Arm
 ;;^UTILITY(U,$J,358.3,5014,2)
 ;;=^271876
 ;;^UTILITY(U,$J,358.3,5015,0)
 ;;=680.5^^25^267^2
 ;;^UTILITY(U,$J,358.3,5015,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5015,1,2,0)
 ;;=2^680.5
 ;;^UTILITY(U,$J,358.3,5015,1,5,0)
 ;;=5^Furuncle Of Buttock
 ;;^UTILITY(U,$J,358.3,5015,2)
 ;;=^271878
 ;;^UTILITY(U,$J,358.3,5016,0)
 ;;=680.0^^25^267^3
 ;;^UTILITY(U,$J,358.3,5016,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5016,1,2,0)
 ;;=2^680.0
 ;;^UTILITY(U,$J,358.3,5016,1,5,0)
 ;;=5^Furuncle Of Face
 ;;^UTILITY(U,$J,358.3,5016,2)
 ;;=^271873
 ;;^UTILITY(U,$J,358.3,5017,0)
 ;;=680.7^^25^267^4
 ;;^UTILITY(U,$J,358.3,5017,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5017,1,2,0)
 ;;=2^680.7
 ;;
 ;;$END ROU IBDEI0BE
